Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin

Despite improvements in treatment regimens for osteosarcoma (OS) patients, survival rate has not increased over the last two decades. New treatment modalities are therefore warranted. Preclinical results with conditionally replicative adenoviruses (CRAds) to treat OS are promising. One type of CRAd...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Graat, H C A, Witlox, M A, Schagen, F H E, Kaspers, G J L, Helder, M N, Bras, J, Schaap, G R, Gerritsen, W R, Wuisman, P I J M, van Beusechem, V W
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361338/
https://ncbi.nlm.nih.gov/pubmed/16736005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados